Physician profile
Emily E Cook
NPI 1770748758
$900.77
in general payments reported to CMS, 2019-2025
12 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $101 · 2021: $21.35 · 2022: $142 · 2023: $288 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $249.81 | 2022-2023 | |
| Allergan, INC. | $195.99 | 2019-2021 | |
| Sight Sciences, INC. | $147.33 | 2023 | Tearcare System |
| Aerie Pharmaceuticals, INC. | $113.96 | 2019 | |
| Abbvie INC. | $32.58 | 2022-2023 | Xen Glaucoma Treatment System |
| Alcon Vision LLC | $30.08 | 2025 | Rocklatan |
| Amgen INC. | $27.76 | 2025 | Tepezza |
| New World Medical,INC. | $23.34 | 2025 | Streamline, Via360, Ahmed Glaucoma Valve |
| Sun Pharmaceutical Industries INC. | $22.94 | 2019 | |
| Dompe US, INC. | $19.97 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $19.50 | 2025 | Tyrvaya |
| Glaxosmithkline, LLC. | $17.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.